In case you missed it: October 5 to October 9
It was a very busy week for the Contemporary Pediatrics team.
This week’s top articles included:
Dr. Anthony Fauci talks COVID-19 at AAP conference
During the virtual 2020 American Academy of Pediatrics National Conference & Exhibition, Dr. Anthony Fauci sat down with Dr. Sally Goza to talk about the history of COVID-19, multisystem inflammatory syndrome in children, and the potential vaccine.
How to overcome discomfort with the genital exam
Premi Suresh, MD, addressed the discomfort that many clinicians may feel when faced with a genital exam and offered guidance on how to become more comfortable as well as common findings.
Climate change and pediatric infectious disease
The focus on climate change is frequently on the macro level, but the ramifications can be felt closer to home as well. Saul R. Hymes, MD, discusses its impact on tick-borne diseases and other disease.
Keep an eye out for congenital cytomegalovirus
A presentation at the virtual 2020 American Academy of Pediatrics National Conference & Exhibition offers insight into the prevalence of congenital cytomegalovirus and potential treatment plans.
Having "the talk" with teen patients
June 17th 2022A visit with a pediatric clinician is an ideal time to ensure that a teenager knows the correct information, has the opportunity to make certain contraceptive choices, and instill the knowledge that the pediatric office is a safe place to come for help.
Meet the Board: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI
May 20th 2022Contemporary Pediatrics sat down with one of our newest editorial advisory board members: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI to discuss what led to her career in medicine and what she thinks the future holds for pediatrics.
Study finds reduced CIN3+ risk from early HPV vaccination
April 17th 2024A recent study found that human papillomavirus vaccination when aged under 20 years, coupled with active surveillance for cervical intraepithelial neoplasia grade 2, significantly lowers the risk of cervical intraepithelial neoplasia grade 3 or cervical cancer.
